17 completed, 6 unknown, 2 terminated, 1 recruiting. 13 Phase 3, 10 Phase 2, 3 Phase 4, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 11, Terminated 1, Unknown 1 |
| Phase 2 | 10 | Completed 5, Terminated 2, Unknown 2, Recruiting 1 |
| Phase 4 | 3 | Unknown 2, Completed 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow VAP-cyclo protocol: new trials by email Literature Review of VAP-cyclo protocol trials Research Report on VAP-cyclo protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL) linperlisib combined with CHOP regimen - Nodal T-follicular Helper Cell Lymphoma | Phase 2 | Recruiting | Peking University | 54 | 2023-11-28 | 2024-04-04 |
| Go-CHOP as the Frontline Therapy for PTCL Golidocitinib, CHOP Regimen - Peripheral T Cell Lymphoma | Phase 2 | Unknown | Henan Cancer Hospital | 45 | 2023-08-03 | 2023-09-01 |
| Treatment of Newly Diagnosed Peripheral T-cell Lymphoma Apatinib, CHOP Regimen - Newly Diagnosed Peripheral T-cell Lymphoma | Phase 4 | Unknown | Zhengzhou University | 100 | 2018-09-01 | 2018-08-15 |
| Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients Obinutuzumab, Ibrutinib, CHOP - Richter Syndrome | Phase 2 | Terminated | Northwell Health | 3 | 2017-06-19 | 2023-06-01 |
| Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma) Chidamide - Peripheral T Cell Lymphoma | Not applicable | Unknown | The First Affiliated Hospital of Soochow University | 39 | 2017-06-15 | 2017-08-31 |
| Treatment of Diffuse Large B Cell Lymphoma Yangzhengxiaoji capsule combined with CHOP regimen, CHOP regimen - Diffuse Large B Cell Lymphoma | Phase 4 | Unknown | Mingzhi Zhang | 120 | 2012-09-01 | 2015-12-30 |
| Treatment of Peripheral T-cell Lymphoma GDPT regimen, CHOP regimen - Peripheral T-cell Lymphoma | Phase 4 | Completed | Mingzhi Zhang | 100 | 2011-08-01 | 2016-10-05 |
| Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL CEOP regimen, CHOP regimen - Lymphoma | Phase 3 | Completed | Fudan University | 398 | 2009-03-01 | 2014-08-20 |
| High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk Rituximab and CHOP regimen + PBSCT - HIV-related Lymphoma, HIV Infections | Phase 2 | Completed | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 27 | 2007-01-01 | 2016-08-19 |
| Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma CHOP regimen, cyclophosphamide, doxorubicin hydrochloride - Lymphoma, Small Intestine Cancer | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 25 | 2004-01-01 | 2012-09-24 |
| Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma CHOP regimen, EPOCH regimen, cyclophosphamide - Lymphoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 3 | 2003-03-01 | 2012-09-24 |
| Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL filgrastim, rituximab, CHOP regimen - Leukemia | Phase 2 | Completed | Swiss Cancer Institute | 43 | 2002-06-01 | 2012-05-15 |
| Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | NCIC Clinical Trials Group | 824 | 2001-05-08 | 2020-04-01 |
| Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma filgrastim, rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | German High-Grade Non-Hodgkin's Lymphoma Study Group | 1506 | 2001-01-01 | 2021-05-18 |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma rituximab, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | University of Nebraska | 1999-09-01 | 2024-09-23 | |
| Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma rituximab, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 475 | 1999-05-01 | 2021-02-15 |
| S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma CHOP regimen, cyclophosphamide, doxorubicin hydrochloride - Lymphoma | Phase 2 | Completed | SWOG Cancer Research Network | 102 | 1999-05-01 | 2013-01-24 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma filgrastim, rituximab, CHOP regimen - Lymphoma | Phase 3 | Completed | National Cancer Institute (NCI) | 120 | 1999-01-01 | 2013-02-08 |
| Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma filgrastim, CHOP regimen, carboplatin - Lymphoma | Phase 1 / Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 24 | 1998-06-01 | 2013-06-24 |
| Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma bleomycin sulfate, CHOP regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | Lymphoma Trials Office | 310 | 1998-01-01 | 2013-06-26 |
Showing 20 of 26. Sign in to see all of them.
Lymphoma (17) · Lymphoma, Large B-Cell, Diffuse (12) · Lymphoma, Follicular (8) · Lymphoma, Non-Hodgkin (8) · Lymphoma, Large-Cell, Immunoblastic (6) · Lymphoma, Large-Cell, Anaplastic (4) · Lymphoma, T-Cell, Peripheral (4) · Burkitt Lymphoma (3) · Lymphoma, Mantle-Cell (3) · Immunoblastic Lymphadenopathy (2) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, T-Cell, Cutaneous (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2)
European Organisation for Research and Treatment of Cancer - EORTC (3) · Lymphoma Trials Office (2) · Mingzhi Zhang (2) · National Cancer Institute (NCI) (2) · SWOG Cancer Research Network (2) · Swiss Cancer Institute (2) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · Eastern Cooperative Oncology Group (1) · Fudan University (1) · German High-Grade Non-Hodgkin's Lymphoma Study Group (1) · Henan Cancer Hospital (1) · M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · NCIC Clinical Trials Group (1) · Northwell Health (1)
United States (8) · China (7) · Belgium (3) · Canada (3) · Italy (3) · Switzerland (3) · United Kingdom (3) · Denmark (2) · Egypt (2) · France (2) · Germany (2) · Netherlands (2) · Norway (2) · South Africa (2) · Australia (1)
Mingzhi Zhang, Pro,Dr (2) · Carol S. Portlock, MD (1) · Daniel C. Betticher, MD (1) · David C. Linch (1) · David P. Schenkein, MD (1) · Eva K. Kimby, MD, PhD (1) · Fernando Cabanillas, MD (1) · Giuseppe Rossi, MD (1) · Igor Aurer, MD, PhD (1) · Jacqueline Barrientos, MD (1) · James K. Weick, MD (1) · Julie M Vose, MD (1) · Keshu Zhou, Dr. (1) · Kevin Imrie, MD (1) · Lawrence D. Kaplan, MD (1)
PMID 12738671, PMID 15914552, PMID 16449523, PMID 16648042, PMID 16754935, PMID 16873669, PMID 16888080, PMID 16896003, PMID 18226581, PMID 18400558, PMID 20218808, PMID 20368567, PMID 20371683, PMID 20439641, PMID 20735398, PMID 20942843, PMID 22337718, PMID 23335369, PMID 24171516, PMID 24493716, PMID 24625415, PMID 25135997, PMID 25403207, PMID 27967294, PMID 28398499, PMID 28597542, PMID 32550864, PMID 34384709, PMID 39227453, PMID 39229263
U10CA032102 (2), P30CA036727 (1)